Skip to main content
Year archive

Luye Pharma Group Limited — 2022 filings

All 105 regulatory filings released by Luye Pharma Group Limited (2186) in 2022, sourced directly from the official regulator.

105 Filings
2022 Period
2022 filings (105)
Filing Released Lang
Terms of Reference for Remuneration Committee of the board of directors of the Company
Regulatory Filings
2022-12-30 English
PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH ON THE MAIN BOARD OF THE STOCK EXCHANGE - LISTING OF BOAN BIOTECH AND COMMENCEMENT OF DEALINGS IN THE H SHARES OF BOAN BIOTECH
Regulatory Filings
2022-12-30 English
PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH ON THE MAIN BOARD OF THE STOCK EXCHANGE - GLOBAL OFFERING
Regulatory Filings
2022-12-29 English
VOLUNTARY ANNOUNCEMENT - APPLICATION FOR MARKETING AUTHORISATION OF PALIPERIDONE PALMITATE INJECTION (LY03010) IN CHINA HAS BEEN ACCEPTED
Regulatory Filings
2022-12-28 English
PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH ON THE MAIN BOARD OF THE STOCK EXCHANGE - PUBLICATION OF PROSPECTUS BY BOAN BIOTECH - EXPECTED SIZE OF THE GLOBAL OFFERING AND OFFER PRICE
Regulatory Filings
2022-12-19 English
PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH ON THE MAIN BOARD OF THE STOCK EXCHANGE - BASIS OF ASSURED ENTITLEMENT OF QUALIFYING SHAREHOLDERS IN THE PREFERENTIAL OFFERING
Regulatory Filings
2022-12-16 English
PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH ON THE MAIN BOARD OF THE STOCK EXCHANGE POST HEARING INFORMATION PACK
Regulatory Filings
2022-12-11 English
Interim Report 2022
Regulatory Filings
2022-12-06 English
UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH - RECORD DATE FOR ASSURED ENTITLEMENT AND CLOSURE OF REGISTER OF MEMBERS
Regulatory Filings
2022-12-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2022
Regulatory Filings
2022-12-02 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2022-12-01 English
VOLUNTARY ANNOUNCEMENT - FIRST PATIENT DOSED IN A PHASE II CLINICAL STUDY IN CHINA FOR NEW CLASS 1 DRUG LY03014
Regulatory Filings
2022-11-29 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 SEPTEMBER 2022
Regulatory Filings
2022-11-21 English
VOLUNTARY ANNOUNCEMENT - LY03010 ACHIEVED THE ENDPOINTS OF PIVOTAL STUDY IN THE U.S.
Regulatory Filings
2022-11-20 English
PROFIT WARNING
Regulatory Filings
2022-11-14 English
VOLUNTARY ANNOUNCEMENT - MARKETING AUTHORIZATION OF DENOSUMAB INJECTION (BOYOUBEI) APPROVED BY NMPA
Regulatory Filings
2022-11-10 English
NOTICE OF BOARD MEETING
Regulatory Filings
2022-11-07 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2022
Regulatory Filings
2022-11-03 English
VOLUNTARY ANNOUNCEMENT - MARKETING REGISTRATION OF CLASS 1 INNOVATIVE ANTIDEPRESSANT RUOXINLIN (LY03005) APPROVED BY NMPA
Regulatory Filings
2022-11-03 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2022-11-01 English
VOLUNTARY ANNOUNCEMENT - APPROVAL OBTAINED FOR INITIATING CLINICAL TRIAL FOR THE BA2101 INJECTION, AN INNOVATIVE LONG-ACTING MONOCLONAL ANTIBODY IN CHINA
Regulatory Filings
2022-10-27 English
List of Directors and their Roles and Functions
Regulatory Filings
2022-10-17 English
RESIGNATION OF EXECUTIVE DIRECTOR
Regulatory Filings
2022-10-17 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2022
Regulatory Filings
2022-10-07 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2022-10-03 English
Interim Report 2022
Regulatory Filings
2022-09-28 English
VOLUNTARY ANNOUNCEMENT - APPROVAL OBTAINED FOR INITIATING CLINICAL TRIAL FOR THE GROUP'S NEW DRUG LY03015 IN THE U.S.
Regulatory Filings
2022-09-13 English
ISSUE OF CONVERTIBLE BONDS
Regulatory Filings
2022-09-13 English
VOLUNTARY ANNOUNCEMENT - APPROVAL OBTAINED FOR INITIATING CLINICAL TRIAL FOR THE BROADLY NEUTRALIZING ANTIBODY AGAINST SARS-COV-2 IN CHINA
Regulatory Filings
2022-09-12 English
VOLUNTARY ANNOUNCEMENT - APPROVAL OBTAINED FOR INITIATING CLINICAL TRIAL FOR THE INNOVATIVE ANTIBODY DRUG BA1106 IN CHINA
Regulatory Filings
2022-09-07 English
PROPOSED ISSUE OF CONVERTIBLE BONDS
Regulatory Filings
2022-09-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2022
Regulatory Filings
2022-09-02 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2022-09-01 English
ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2022
Regulatory Filings
2022-08-29 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 22 AUGUST 2022
Regulatory Filings
2022-08-22 English
NOTICE OF BOARD MEETING
Regulatory Filings
2022-08-17 English
ISSUE OF CONVERTIBLE BONDS
Regulatory Filings
2022-08-16 English
VOLUNTARY ANNOUNCEMENT - NEW DRUG APPLICATION FOR NEW INDICATION OF GOSERELIN ACETATE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY01005) FOR BREAST CANCER HAS BEEN ACCEPTED IN CHINA
Regulatory Filings
2022-08-15 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2022-08-05 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2022
Regulatory Filings
2022-08-03 English
PROPOSED ISSUE OF CONVERTIBLE BONDS
Regulatory Filings
2022-07-28 English
CHANGE OF ADDRESS OF HONG KONG BRANCH SHARE REGISTRAR AND TRANSFER OFFICE
Regulatory Filings
2022-07-25 English
ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT 2021/22
Regulatory Filings
2022-07-25 English
Form of proxy for use by shareholders at the Annual General Meeting to be convened on Monday, 22 August 2022 at 10:00 a.m.
Regulatory Filings
2022-07-25 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2022-07-25 English
GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES&#x3b; RE-ELECTION OF DIRECTORS&#x3b; RE-APPOINTMENT OF INDEPENDENT AUDITOR&#x3b; AND NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2022-07-25 English
Annual Report 2021/22
Regulatory Filings
2022-07-25 English
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF GOSERELIN ACETATE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY01005) FOR TREATMENT OF BREAST CANCER MET PRIMARY ENDPOINTS IN CHINA
Regulatory Filings
2022-07-24 English
VOLUNTARY ANNOUNCEMENT - PHASE III CLINICAL TRIAL OF ROTIGOTINE EXTENDED-RELEASE MICROSPHERES FOR INJECTION (LY03003) IN PARKINSON'S DISEASE MET PRIMARY ENDPOINT IN CHINA
Regulatory Filings
2022-07-19 English
VOLUNTARY ANNOUNCEMENT - INNOVATIVE DRUG LURBINECTEDIN (LY01017) APPROVED FOR URGENT CLINICAL USE IN HAINAN
Regulatory Filings
2022-07-17 English
VOLUNTARY ANNOUNCEMENT - DULAGLUTIDE INJECTION (BA5101) ENTERED INTO PHASE III CLINICAL TRIAL IN CHINA
Regulatory Filings
2022-07-14 English
COMPLETION OF REDEMPTION OF U.S.$300,000,000 1.50 PER CENT. CONVERTIBLE BONDS DUE 2024
Regulatory Filings
2022-07-14 English
REDEMPTION OF U.S.$300,000,000 1.50 PER CENT. CONVERTIBLE BONDS DUE 2024
Regulatory Filings
2022-07-11 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2022
Regulatory Filings
2022-07-07 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2022-07-06 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 MARCH 2022
Regulatory Filings
2022-06-30 English
PROFIT WARNING
Regulatory Filings
2022-06-29 English
LAPSE OF THE PLACING AGREEMENT
Regulatory Filings
2022-06-21 English
Altered Memorandum of Association and Bye-laws
Regulatory Filings
2022-06-20 English
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 20 JUNE 2022
Regulatory Filings
2022-06-20 English
SUPPLEMENTAL ANNOUNCEMENT - DATE OF BOARD MEETING
Regulatory Filings
2022-06-17 English
DATE OF BOARD MEETING
Regulatory Filings
2022-06-15 English
VOLUNTARY ANNOUNCEMENT - RESULTS OF A PHASE III CLINICAL TRIAL OF CLASS 1 NEW DRUG LY03005 PRESENTED AT THE 2022 APA ANNUAL MEETING
Regulatory Filings
2022-06-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2022
Regulatory Filings
2022-06-07 English
VOLUNTARY ANNOUNCEMENT - RESULTS OF A PHASE I CLINICAL TRIAL OF LURBINECTEDIN AS SECOND-LINE THERAPY IN CHINESE PATIENTS WITH SCLC PRESENTED AT THE 2022 ASCO ANNUAL MEETING
Regulatory Filings
2022-06-06 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2022-06-01 English
Environmental, Social and Governance Report 2021
Regulatory Filings
2022-05-31 English
Next Day Disclosure Return
Regulatory Filings
2022-05-27 English
DISCLOSEABLE TRANSACTION IN RELATION TO THE PROPOSED ACQUISITION OF TIMEPIECES AND ACCESSORIES BUSINESS
Regulatory Filings
2022-05-24 English
PLACING OF NEW SHARES UNDER GENERAL MANDATE
Regulatory Filings
2022-05-19 English
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 20 JUNE 2022
Regulatory Filings
2022-05-17 English
NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2022-05-17 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS AND PROPOSED AMENDMENTS TO BYE-LAWS AND NOTICE OF ANNUAL GENERAL MEETING
Regulatory Filings
2022-05-17 English
PROPOSED AMENDMENTS TO THE BYE-LAWS OF THE COMPANY
Regulatory Filings
2022-05-17 English
UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH
Regulatory Filings
2022-05-16 English
UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH
Regulatory Filings
2022-05-13 English
VOLUNTARY ANNOUNCEMENT - COMPLETION OF PHASE I CLINICAL TRIAL FOR CLASS 1 NEW DRUG LY03014 IN CHINA
Regulatory Filings
2022-05-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2022
Regulatory Filings
2022-05-05 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2022-05-03 English
Annual Report 2021
Regulatory Filings
2022-04-28 English
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF APPLICATION FOR MARKETING AUTHORIZATION IN CHINA FOR RIVASTIGMINE TWICE-WEEKLY TRANSDERMAL PATCH
Regulatory Filings
2022-04-12 English
(Revised) Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2022-04-08 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2022
Regulatory Filings
2022-04-06 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2022-04-01 English
VOLUNTARY ANNOUNCEMENT - GRANT OF EXCLUSIVE RIGHTS TO COMMERCIALIZE NEW DRUG RIVASTIGMINE MD IN MEXICO AND POLAND FROM LUYE TO EXELTIS
Regulatory Filings
2022-03-31 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2021
Regulatory Filings
2022-03-30 English
VOLUNTARY ANNOUNCEMENT - APPROVAL OBTAINED FOR CLASS 1 NEW DRUG LY03005 TO INITIATE PHASE III CLINICAL TRIAL FOR GENERALIZED ANXIETY DISORDER IN CHINA
Regulatory Filings
2022-03-21 English
NOTICE OF BOARD MEETING
Regulatory Filings
2022-03-17 English
CHANGE OF AUDITOR
Regulatory Filings
2022-03-16 English
List of Directors and their Roles and Functions
Regulatory Filings
2022-03-15 English
APPOINTMENT AND RESIGNATION OF INDEPENDENT NON-EXECUTIVE DIRECTORS
Regulatory Filings
2022-03-15 English
Next Day Disclosure Return
Regulatory Filings
2022-03-14 English
VOLUNTARY ANNOUNCEMENT - SUBMISSION OF NEW DRUG APPLICATION FOR LURBINECTEDIN (LY01017) BY THE GROUP IN HONG KONG, CHINA
Regulatory Filings
2022-03-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2022
Regulatory Filings
2022-03-04 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2022-03-01 English
VOLUNTARY ANNOUNCEMENT - NEW INDICATIONS APPROVED FOR BOYOUNUO (BEVACIZUMAB INJECTION) IN CHINA
Regulatory Filings
2022-02-25 English
VOLUNTARY ANNOUNCEMENT - COLLABORATIVE PROMOTION ENTERED INTO WITH BIOSTAR IN RELATION TO UTIDELONE INJECTION IN THE MAINLAND OF CHINA
Regulatory Filings
2022-02-21 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2022
Regulatory Filings
2022-02-07 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2022-02-04 English
VOLUNTARY ANNOUNCEMENT - UPDATE ON THE PROPOSED SPIN-OFF AND SEPARATE LISTING OF BOAN BIOTECH
Regulatory Filings
2022-01-24 English
VOLUNTARY ANNOUNCEMENT - APPROVAL FOR INITIATING CLINICAL TRIALS FOR MONTHLY MICROSPHERE INJECTION NEW DRUG LY03009 FOR PARKINSON'S DISEASE IN THE UNITED STATES
Regulatory Filings
2022-01-19 English
VOLUNTARY ANNOUNCEMENT - ACCEPTANCE OF APPLICATION FOR MARKETING AUTHORIZATION IN CHINA FOR OXYCODONE AND NALOXONE EXTENDED-RELEASE TABLETS (LY021702)
Regulatory Filings
2022-01-17 English
SUPPLEMENTAL ANNOUNCEMENT TO THE ANNUAL REPORT FOR THE YEAR ENDED 31 MARCH 2021
Regulatory Filings
2022-01-10 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2021
Regulatory Filings
2022-01-05 English
Monthly Return of Equity Issuer on Movements in Securities
Regulatory Filings
2022-01-03 English